18 July 2018

LSIPR 50 2018: The entrepreneurial bug

Since its founding in 2000, Flagship Pioneering has set up and fostered the development of more than 100 scientific ventures, resulting in $20 billion in aggregate value, more than 500 issued patents, and more than 50 clinical trials for novel therapeutic agents.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Careers

Moderna VP and regulatory expert moves to private practice

2 February 2026 The third European life sciences hire in recent months brings in-house regulatory expertise from Moderna in Munich.

Careers

Crowell adds tech partner with in-house and private practice expertise

2 February 2026 The seasoned IP leader has left biotech GRAIL to expand the firm’s capabilities in life sciences, technology, and AI in California.

Careers

Winston & Strawn and Taylor Wessing UK seal ‘powerhouse’ merger

30 January 2026 Transatlantic ‘powerhouse’ Winston Taylor is set to launch in May 2026, with a particular focus on technology, life sciences and transatlantic services.

More features

Crowell adds tech partner with in-house and private practice expertise

Sanofi suffers setback in insulin monopoly dispute

Firm adds seven-lawyer team in second major merger

The quantum advantage: IP considerations for the next generation of life sciences innovation

Fed Circ overturns PTAB decision in $83.4m DNA case

Simpson Thacher adds ‘exemplary’ litigator with emerging tech expertise

Novartis win blocks generics relitigating $7.8bn heart drug patent

Leading the arena: WIPR identifies the top US trade secrets specialists of 2025

LSIPR 50 2018: The entrepreneurial bug

More on this story

Editor's picks

Editor's picks

More features